Brian A. Leuthner - 28 Jun 2021 Form 4 Insider Report for ONCOSEC MEDICAL Inc (ONCS)

Role
Interim CEO
Signature
/s/ Brian A. Leuthner
Issuer symbol
ONCS
Transactions as of
28 Jun 2021
Net transactions value
-$43,017
Form type
4
Filing time
29 Jun 2021, 19:42:09 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCS Common Stock Award $0 +192,000 $0.000000 192,000 28 Jun 2021 Direct F1
transaction ONCS Common Stock Sale $43,017 -13,613 -7.1% $3.16* 178,387 28 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONCS Stock Option (Right to Buy) Award $0 +33,000 $0.000000 33,000 28 Jun 2021 Common Stock 33,000 $3.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects restricted stock units (RSUs) that were 25% vested upon grant with the remaining 75% vesting in equal quarterly installments over the next two years.
F2 In connection with the vesting of 48,000 RSUs on June 28, 2021, a total of 13,613 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.
F3 The option is 25% vested upon grant with the remaining 75% vesting in equally in quarterly installments over the next two years.